Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.

Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, Hazra A, Schernhammer ES, Hunter DJ, Giovannucci EL, Fuchs CS, Ogino S.

Mol Cancer. 2010 May 27;9:125. doi: 10.1186/1476-4598-9-125.

2.

Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.

Shima K, Nosho K, Baba Y, Cantor M, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.

Int J Cancer. 2011 Mar 1;128(5):1080-94. doi: 10.1002/ijc.25432. Review.

3.

Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

Kim JH, Kang GH.

World J Gastroenterol. 2014 Apr 21;20(15):4230-43. doi: 10.3748/wjg.v20.i15.4230. Review.

4.

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.

Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S.

J Pathol. 2010 Dec;222(4):350-66. doi: 10.1002/path.2774. Review.

5.

Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.

Baba Y, Murata A, Watanabe M, Baba H.

Surg Today. 2014 Oct;44(10):1807-16. doi: 10.1007/s00595-013-0763-6. Epub 2013 Oct 23. Review.

PMID:
24150097
6.

Molecular biomarkers in colorectal carcinoma.

Puerta-García E, Cañadas-Garre M, Calleja-Hernández MÁ.

Pharmacogenomics. 2015;16(10):1189-222. doi: 10.2217/PGS.15.63. Epub 2015 Aug 3. Review.

PMID:
26237292
7.

Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.

Bae JM, Kim JH, Kang GH.

Histol Histopathol. 2013 May;28(5):585-95. doi: 10.14670/HH-28.585. Epub 2013 Jan 23. Review.

PMID:
23341177
8.

Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT.

Oncogene. 2014 Jun 5;33(23):2949-55. doi: 10.1038/onc.2013.244. Epub 2013 Jun 24. Review.

9.

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Ogino S, Chan AT, Fuchs CS, Giovannucci E.

Gut. 2011 Mar;60(3):397-411. doi: 10.1136/gut.2010.217182. Epub 2010 Oct 29. Review.

10.

LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis.

Barchitta M, Quattrocchi A, Maugeri A, Vinciguerra M, Agodi A.

PLoS One. 2014 Oct 2;9(10):e109478. doi: 10.1371/journal.pone.0109478. eCollection 2014. Review.

11.

Integration of genome scale data for identifying new players in colorectal cancer.

Sokolova V, Crippa E, Gariboldi M.

World J Gastroenterol. 2016 Jan 14;22(2):534-45. doi: 10.3748/wjg.v22.i2.534. Review.

12.

Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.

Lim B, Kim JH, Kim M, Kim SY.

World J Gastroenterol. 2016 Jan 21;22(3):1190-201. doi: 10.3748/wjg.v22.i3.1190. Review.

13.

The Fine LINE: Methylation Drawing the Cancer Landscape.

Miousse IR, Koturbash I.

Biomed Res Int. 2015;2015:131547. doi: 10.1155/2015/131547. Epub 2015 Sep 13. Review.

14.

Genetics of colorectal cancer.

Munteanu I, Mastalier B.

J Med Life. 2014 Oct-Dec;7(4):507-11. Review.

15.

Genetic and epigenetic traits as biomarkers in colorectal cancer.

Berg M, Søreide K.

Int J Mol Sci. 2011;12(12):9426-39. doi: 10.3390/ijms12129426. Epub 2011 Dec 16. Review.

16.

Colorectal carcinogenesis: road maps to cancer.

Worthley DL, Whitehall VL, Spring KJ, Leggett BA.

World J Gastroenterol. 2007 Jul 28;13(28):3784-91. Review.

17.

Cancer immunology--analysis of host and tumor factors for personalized medicine.

Ogino S, Galon J, Fuchs CS, Dranoff G.

Nat Rev Clin Oncol. 2011 Aug 9;8(12):711-9. doi: 10.1038/nrclinonc.2011.122. Review.

18.

Important molecular genetic markers of colorectal cancer.

Kudryavtseva AV, Lipatova AV, Zaretsky AR, Moskalev AA, Fedorova MS, Rasskazova AS, Shibukhova GA, Snezhkina AV, Kaprin AD, Alekseev BY, Dmitriev AA, Krasnov GS.

Oncotarget. 2016 Aug 16;7(33):53959-53983. doi: 10.18632/oncotarget.9796. Review.

19.

Many colorectal cancers are "flat" clonal expansions.

Siegmund KD, Marjoram P, Tavaré S, Shibata D.

Cell Cycle. 2009 Jul 15;8(14):2187-93. Epub 2009 Jul 1. Review.

20.

The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers.

Mahathre MM, Rida PC, Aneja R.

J Biomed Res. 2016 Nov;30(6):441-451. doi: 10.7555/JBR.30.20150109. Epub 2015 Nov 10. Review.

Supplemental Content

Support Center